Terms: = Breast cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300 AND Prognosis
37 results:
1. Roles and signaling pathways of CITED1 in tumors: overview and novel insights.
Chen W; Jiang J; Gao J; Wang G; Wang R; Lv J; Ben J
J Int Med Res; 2024 Jan; 52(1):3000605231220890. PubMed ID: 38190845
[TBL] [Abstract] [Full Text] [Related]
2. Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract] [Full Text] [Related]
3. ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression.
Zhang Y; Wang W; Min J; Liu S; Wang Q; Wang Y; Xiao Y; Li X; Zhou Z; Liu S
Cell Rep; 2023 Jun; 42(6):112654. PubMed ID: 37342906
[TBL] [Abstract] [Full Text] [Related]
4. The activation of ep300 by F11R leads to EMT and acts as a prognostic factor in triple-negative breast cancers.
Li CH; Fang CY; Chan MH; Lu PJ; Ger LP; Chu JS; Chang YC; Chen CL; Hsiao M
J Pathol Clin Res; 2023 May; 9(3):165-181. PubMed ID: 36782375
[TBL] [Abstract] [Full Text] [Related]
5. Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway.
Wang HC; Luo CW; Chen TY; Chen YZ; Fang SY; Lai CY; Hung WC; Wu CC; Chen LT; Liu YC; Pan MR
Life Sci; 2022 Dec; 311(Pt A):121135. PubMed ID: 36349605
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in breast cancer.
Stella S; Vitale SR; Massimino M; Motta G; Longhitano C; Lanzafame K; Martorana F; Fazzari C; Vecchio GM; Tirrò E; Inzerilli N; Carciotto R; Manzella L; Caruso M; Vigneri P
Cancer Genomics Proteomics; 2022; 19(4):464-476. PubMed ID: 35732329
[TBL] [Abstract] [Full Text] [Related]
7. PABPC1-induced stabilization of IFI27 mRNA promotes angiogenesis and malignant progression in esophageal squamous cell carcinoma through exosomal miRNA-21-5p.
Zhang Y; Chen C; Liu Z; Guo H; Lu W; Hu W; Lin Z
J Exp Clin Cancer Res; 2022 Mar; 41(1):111. PubMed ID: 35346324
[TBL] [Abstract] [Full Text] [Related]
8. Machine Learning Identifies Pan-cancer Landscape of Nrf2 Oxidative Stress Response Pathway-Related Genes.
Li N; Zhan X
Oxid Med Cell Longev; 2022; 2022():8450087. PubMed ID: 35242279
[TBL] [Abstract] [Full Text] [Related]
9. RNA-binding protein p54
Shen M; Zhang R; Jia W; Zhu Z; Zhao L; Huang G; Liu J
Cell Death Dis; 2022 Jan; 13(1):42. PubMed ID: 35013116
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Model for De Novo and Recurrent Metastatic breast cancer.
Barcenas CH; Song J; Murthy RK; Raghavendra AS; Li Y; Hsu L; Carlson RW; Tripathy D; Hortobagyi GN
JCO Clin Cancer Inform; 2021 Aug; 5():789-804. PubMed ID: 34351787
[TBL] [Abstract] [Full Text] [Related]
11. [Clinical features and prognosis of patients with leptomeningeal metastases].
Zhang ML; Ma WF; Gao XY; Shi YY; Liu HQ; Jiang YS; Qin LZ; Yuan LP; Li W; Zhang JW
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(16):1154-1159. PubMed ID: 33902246
[No Abstract] [Full Text] [Related]
12. NEDDylation negatively regulates ERRβ expression to promote breast cancer tumorigenesis and progression.
Naik SK; Lam EW; Parija M; Prakash S; Jiramongkol Y; Adhya AK; Parida DK; Mishra SK
Cell Death Dis; 2020 Aug; 11(8):703. PubMed ID: 32839427
[TBL] [Abstract] [Full Text] [Related]
13. A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer.
Li HM; Bi YR; Li Y; Fu R; Lv WC; Jiang N; Xu Y; Ren BX; Chen YD; Xie H; Wang S; Lu T; Wu ZQ
Sci Adv; 2020 Apr; 6(17):eaaw8500. PubMed ID: 32494626
[TBL] [Abstract] [Full Text] [Related]
14. Upregulation of GPNCA is associated with poor prognosis through enhancement of tumor growth via regulating GSK3B.
Liao W; Liu F; Zhang H; Liao W; Xu N; Xie W; Zhang Y
Sci Rep; 2020 Feb; 10(1):2044. PubMed ID: 32029792
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptional Coactivator TAZ Negatively Regulates Tumor Suppressor p53 Activity and Cellular Senescence.
Miyajima C; Kawarada Y; Inoue Y; Suzuki C; Mitamura K; Morishita D; Ohoka N; Imamura T; Hayashi H
Cells; 2020 Jan; 9(1):. PubMed ID: 31936650
[TBL] [Abstract] [Full Text] [Related]
16. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation.
Jia X; Shi L; Wang X; Luo L; Ling L; Yin J; Song Y; Zhang Z; Qiu N; Liu H; Deng M; He Z; Li H; Zheng G
Cell Death Dis; 2019 May; 10(5):373. PubMed ID: 31073122
[TBL] [Abstract] [Full Text] [Related]
17. Tumour suppressor ep300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
Asaduzzaman M; Constantinou S; Min H; Gallon J; Lin ML; Singh P; Raguz S; Ali S; Shousha S; Coombes RC; Lam EW; Hu Y; Yagüe E
Breast Cancer Res Treat; 2017 Jun; 163(3):461-474. PubMed ID: 28341962
[TBL] [Abstract] [Full Text] [Related]
18. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783
[TBL] [Abstract] [Full Text] [Related]
19. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
Ali A; Ielciu I; Alkreathy HM; Khan AA
Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic significance of Ubiquilin1 expression in invasive breast cancer.
Wang Y; Lu J; Zhao X; Feng Y; Lv S; Mu Y; Wang D; Fu H; Chen Y; Li Y
Cancer Biomark; 2015; 15(5):635-43. PubMed ID: 26406952
[TBL] [Abstract] [Full Text] [Related]
[Next]
